Population Pharmacokinetics and Target Attainment Analysis of Vancomycin after Intermittent Dosing in Adults with Cystic Fibrosis
V. Yellepeddi, B. Lindley, E. Radetich, S. Kumar, Z. N. Bhakta, L. Leclair, M. Parrot, D. C. Young
This study develops a population pharmacokinetic model for vancomycin in adults with cystic fibrosis and evaluates dosing scenarios to achieve target drug exposure.
bioRxiv · Jul 28, 2023Pharmacology & Toxicology